UnknownPhase 2NCT00979160
Evaluation of Response of Dasatinib to Treat Mastocytosis
Studying Mastocytosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Federico II University
- Principal Investigator
- Massimo Triggiani, MDUniversità Federico II
- Intervention
- Dasatinib(drug)
- Enrollment
- 30 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2009 – 2012
Study locations (12)
- Istituto di ematologia "L e A Seragnoli" - Policlinico universitario Sant'Orsola-Malpighi, Bologna, Italy
- Dipartimento di Ematologia - S.O.D. di Ematologia Università degli Studi di Firenze - Azienda Ospedaliera Careggi, Florence, Italy
- Divisione di Ematologia Ospedale Niguarda Ca' Grande, Milan, Italy
- Divisione di Allergologia e Immunologia Clinica, Università Federico II, Naples, Italy
- Divisione di Ematologia Università di Torino Ospedale San Luigi Gonzaga, Orbassano (TO), Italy
- Istituto di Ematologia Università degli Studi di Pavia - Policlinico S. Matteo IRCCS, Pavia, Italy
- Unità di Ematologia e Trapianto Osseo CROB, Centro di Riferimento Oncologico di Basilicata +39 0972 726729 Fax +30 0972 726217 e-mail: p.musto@crob.it, Rionero in Vulture (Pz), Italy
- Ematologia Tor Vergata University Hospital, Roma, Italy
- Divisione di Ematologia Policlinico Universitario "Agostino Gemelli", Roma, Italy
- Ematologia e Trapianti Università degli Studi di Siena - Policlinico S. Maria alle Scotte, Siena, Italy
- Divisione di Ematologia e Trapianto Midollo Osseo Azienda Ospedaliero-Universitaria "Santa Maria della Misericordia", Udine, Italy
- Sezione di Ematologia - Dipartimento di Medicina Clinica e Sperimentale Policlinico G.B.Rossi - Università degli Studi di Verona, Verona, Italy
Collaborators
University of Bologna
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00979160 on ClinicalTrials.govOther trials for Mastocytosis
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07328178Analysis of the Role of IgE Proteoforms in Health and DiseaseKU Leuven
- RECRUITINGPHASE4NCT06748001Avapritinib Rollover StudyBlueprint Medicines Corporation
- RECRUITINGNCT06466889Mastocytosis Registry (of Zurich)University of Zurich
- ACTIVE NOT RECRUITINGNCT06065007Quality of Life and Disease-related Symptoms in Individuals With Systemic MastocytosisUppsala University
- RECRUITINGPHASE1NCT06327685Avapritinib With Decitabine in Patients With SM-AHNH. Lee Moffitt Cancer Center and Research Institute
- RECRUITINGNCT06440148Relationship Between Circulating Sclerostin and Bone Lesions in Patients With MastocytosisMedical University of Lublin
- RECRUITINGNCT00044122Study of Factors Regulating Mast Cell ProliferationNational Institute of Allergy and Infectious Diseases (NIAID)